Thank you, Neal. Good morning, everyone. As Neal mentioned, we are very excited about the Variperm acquisition. Let me hit some of the details of the transaction and financial highlights. This week we signed agreements to acquire the equity of Variperm for total consideration of 2 million shares of FET stock and $150 million of cash. As of signing, this equated to roughly $195 million of total consideration, or 3.7 times Variperm’s trailing 12 months of EBITDA. We expect the transaction to close in January following Canadian regulatory approval and satisfaction of other customary closing conditions. To give context to the regulatory review, FET and Variperm did not provide overlapping products or services. In addition, to avoid closing delays, all sources of cash have been secured and leave the combined company with a conservative amount of leverage and adequate liquidity to both manage future obligations and fund organic growth. Cash consideration for the transaction will be funded through $90 million of cash from on hand balances and borrowings under our ABL credit facility and from the funding of a $60 million seller term loan. Prior to closing the Variperm acquisition, we will explore an alternative financing arrangement to the seller term loan. Following closing and without regard to any alternative financing arrangement, we expect net leverage to be 1.9 times EBITDA with liquidity of roughly $140 million. I am pleased to announce that in conjunction with the acquisition, FET lenders agree to amend our ABL credit facility to among other things, permit the Variperm acquisition, increase the aggregate revolving commitments from $179 million to $250 million and extend the maturity date to September 2028 and allow the seller term loan. The amendment is conditioned upon the closing of the acquisition. Once finalized, the expansion of the revolver is advantageous to FET and allows us to increase our borrowing base by between $20 million and $25 million based on including Variperm working capital. We are thankful to our banking group for their continued support of our growth. These banks include Wells Fargo, JPMorgan, Bank of America and Amegy and we are pleased to welcome Goldman Sachs who has joined our credit facility as a lender. The seller term loan would mature in three years and is pre-payable at any time and without penalty. The interest rate of 11% is subject to escalation after the first anniversary of the loan. We structured the seller loan with longer maturity than a traditional bridge with terms that fit within our existing debt arrangements. If we utilize the seller loan, we expect to be able to retire our remaining 9% senior secured notes in the third quarter 2024 without seeking any additional external funding. This structure puts our balance sheet in a strong position. Between the mix of stock and cash consideration, the seller term loan and the credit facility amendment, we believe we have the appropriate leverage, liquidity and visibility for us to move forward confidently with the acquisition of Variperm. Neal has already covered the industrial logic between Variperm and FET, which we are excited about. Let me provide a bit more color on the financial merits of the transaction before shifting to FET’s third quarter results. The transaction’s valuation at 3.7 times trailing 12 months EBITDA provides meaningful accretion for FET. More importantly, the combination creates a business with increased EBITDA, strong EBITDA margins and significant free cash flow. On a combined basis, the company’s revenue increases to $873 million, EBITDA increases to $121 million and EBITDA margin improves to 14%. Net of incremental interest combined free cash flow increases to $70 million. Shortly after closing, we will complete our purchase accounting analysis. Then we’ll have a more accurate approximation of pro forma net income, which we expect to be noteworthy. Let me provide directionality to our per share metrics. While share count will increase by just under 20%, EBITDA improves 77%, free cash flow increases 84% and net income improve substantially. The per share improvement in all of these metrics will be significant and this is another reason why we’re so excited about the transaction. Now turning to third quarter FET results. Sequentially, our consolidated revenue decreased by $6 million. As Neal detailed earlier, the rapid decrease in U.S. completions activity drove our stimulation and intervention revenues down by $14 million. As pressure pumping customers idled fleets, they slowed purchases of consumable products and delayed demand for stimulation related capital equipment such as power ends, manifold trailers, hoses and radiators. Despite the decline in revenue, EBITDA fell by only $1 million. In the middle of the third quarter, realizing that U.S. market conditions had yet to bottom, our teams took action to control costs. In the quarter, we reduced expenses by over $1 million through headcount and variable cost reductions. Highlighting international revenue, similar to the last quarter, FET’s international sales growth nearly offset softer U.S. market conditions. Revenue outside the U.S. increased by $10 million sequentially or roughly 15%, driven by a significant increase in shipments for coiled tubing and an increase in project revenues for our Forum process technology product family. Most of these increases were recognized in the Middle East region, where nearly all product lines saw revenue growth. And total revenue increased approximately 50%, benefiting from a strong international tailwind, non-U.S. revenues accounted for 42% of our total revenue. The Drilling & Downhole segment had revenue and EBITDA growth of $500,000. Drilling product line revenues declined with activity in the U.S. while Downhole and subsea revenues increased. A more favorable mix of products and our aforementioned cost management actions supported EBITDA margins, which increased by 50 basis points. Segment book-to-bill ratio was 117% as we booked an order for four Perry XLX work class ROV systems. We remain excited about the continued strengthening outlook for international drilling and subsea opportunities as customers add capacity and upgrade equipment to support future oil and gas production and offshore wind farm development. Completion segment revenue and EBITDA were impacted this quarter as the dramatic decline in well completion activity slowed demand for our stimulation intervention products, where revenue declined by 30%. Our global tubing business provided the bright spot for the quarter. Revenues jumped on international shipments and profit drop through in the business was strong as the team favorably managed costs in the quarter. Our segment book-to-bill ratio was 104%, slightly higher than we would expect for these activity based product lines. Our production segment continues to improve and provide consistent results. Segment book-to-bill ratio was 105%, driven by an improvement in orders for our Valve Solutions product line. Revenue increased sequentially and on a year-over-year basis and EBITDA margins continue to improve, reaching 6.8% this quarter, up nearly double from a year ago. Now, let me share with you our fourth quarter forecast. Neal discussed how we see the markets going forward. Our fourth quarter is in line with third quarter results, with revenue and EBITDA ranges of $170 million to $190 million and $15 million to $19 million, respectively. With this forecast, our full year EBITDA is expected to be between $67 million and $71 million. This estimate for the full year, 2023 is lower than our forecast provided in last quarter’s call, driven by softer U.S. activity in both the third and fourth quarters. We remain confident in a long-term increasing market outlook as the world solves a structural shortfall in energy supply. Here are a few details for modeling purposes. In the fourth quarter, we anticipate corporate costs to be generally in line with the third quarter, interest expense to be $5 million and depreciation and amortization expense of roughly $9 million. For the full year, cash income taxes are expected to be around $8 million, primarily due to Canadian income. Capital expenditures for 2023 are expected to remain below $10 million. Turning to cash and the balance sheet, we generated free cash flow of $24 million, driven by a decrease in net working capital from strong collections. Given the softness in the U.S. market, our teams continue to drive down working capital by tightening our supply chain and reducing the flow of inbound raw material to match market conditions, and we are working with our customers to achieve more appropriate collection timing. We are pleased with the turnaround in free cash flow in the second half of the year in line with our forecast. We ended the quarter with $37 million of cash on hand and $155 million of availability under our revolving credit facility for total liquidity of $192 million. As of September 30, our net debt was $97 million with a corresponding net leverage ratio of 1.4 times. FET remains well positioned to fund operations with ample liquidity and a strong balance sheet. Let me turn the call back to Neal for closing remarks.